Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cayman Pharma
Neratovice, Czech Republiccaymanpharma.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Cayman Pharma is a specialized pharmaceutical company focused on the development and manufacture of active pharmaceutical ingredients (APIs), with a world-leading expertise in prostaglandins. Based in the Czech Republic, the company operates as a subsidiary of Cayman Chemical and provides high-quality synthetic prostaglandins for both human and veterinary applications. Their capabilities include complex organic synthesis, purification, and full regulatory support for global markets. Cayman Pharma serves as a key contract development and manufacturing organization (CDMO) for specialized small molecule lipid-based therapeutics.
- Therapeutic areas
- CardiovascularOphthalmologyWomen's Health
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Cayman Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cayman Pharma.